The aim of present study was to examine the inhibitory effects of hydroxamic acid derivatives on the melanogenesis. We found that hydroxamic acid moiety was important for anti-melanogenic activity. Compounds 1a and 1b strongly inhibited melanin synthesis via deactivation of tyrosinase. Hydroxamic acid has metal ion chelating ability which is similar to that kojic acid, however, anti-tyrosinase mechanism of compounds 1a and 1b was different from that of kojic acid. They showed noncompetitive inhibition kinetics
Introduction
Skin hyperpigmentation can be dependent on either an increased number of melanocytes or activity of melanogenic enzymes, such as tyrosinase. Tyrosinase 1 is copper-containing enzyme that catalyzes the oxidation of tyrosine into dopa and subsequently dopaquinone. In the formation of melanin, three types of tyrosinase (met-, oxy-, and deoxy-tyrosinase) with different binuclear copper structures of the active site are involved. 2 On the basis of the consideration of copper structure in tyrosinase, many efforts have been focused on the regulation of tyrosinase activity using metal chelating compounds such as kojic acid, 3 catechol, 4 gentisic acid 5 and flavonol. 6 Hydroxamic acids 7 have been the source of much biochemical interest in recent years due to the fact that they show a wide range of biological activities. Much of their activities are due to their chelating properties with metal ions. 8 Although hydroxamic acids were well known as metal ion chelators, their efficacy data on tyrosinase inhibition and melanin biosynthesis were rare. 9 In this study, we synthesized new hydroxamic acid derivatives containing adamantane moiety and evaluated their inhibitory activities on melanogenesis (Fig. 1) .
Results and Discussion
The synthetic pathways are shown in Scheme 1 and Scheme 2. 1-Adamantanecarboxylic acid (2) or monomethyl terephthalate (5) was refluxed in thionyl chloride to afford acid chlorides. These acid chlorides were reacted immediately with methyl 4-aminobenzoate and 1-adamantamine HCl in pyridine to produce corresponding amide derivatives (compounds 3 and 6). The ester groups were hydrolyzed under standard condition (NaOH, ethanol) to produce corresponding acids (compounds 4 and 7). The acids were reacted with ethylchloroformate and N-methyl morpholine in THF to convert the carboxylic acids to an anhydrides. 10 The anhydrides were reacted immediately with hydroxylamine to produce the corresponding hydroxamic acid derivatives (compound 1a and 1b). To investigate the anti-melanogenic properties in detail, hydroxamic acid derivatives (1a and 1b) were assayed together with its synthetic precursors (compound 4 and compound 7) and a standard tyrosinase inhibitor, salicylhydroxamic acid and kojic acid. Their depigmenting effects and cytotoxicities were determined in a murine melanocyte cell line (Melan-a). As shown in Table 1 , compound 1a, containing hydroxamic acid moiety, exhibited potent inhibitory activity (IC 50 = 3.78 μM) with moderate cytotoxicity (IC 50 = 10.92 μM). Compound 1b showed similar behavior. The IC 50 of pigmentation was about 7.46 μM. Compound 4 and 7, precursors of hydroxamic acid derivatives, showed no inhibitory activities. These results suggest that hydroxamic acid moiety played an important role in anti-melanogenic activity. However, salicylhydroxamic acid, 9 known as a tyrosinase inhibitor in literature, exhibited no inhibitory activity in tested concentrations. Adamantane moiety of compound 1a and 1b is also important role for the inhibitory activity as well as hydroxamic acid. Recently, we evaluated compound 1b, 12 as an antioxidant in lipid peroxidation both in vitro and in vivo studies. Adamantane group was adopted as a hydrophobic moiety to optimize antioxidant activity of hydroxamic acid in animal test. In this cell based assay, compound 1a and 1b are also believed to be adequate in cell adhesion and permeation due to its balance in hydrophilic (hydroxamic acid moiety) and hydrophobic character (adamantane moiety). Kojic acid did not inhibit pigmentation at a concentration of up to 2 mM and showed no cytotoxicity at this concentration.
To clarify the influence of hydroxamic acid moiety on melanogenesis, we also measured tyrosinase activity after treatment with compound 1a and 1b. Tyrosinase is the key enzyme in melanin biosynthesis, and a hallmark of differenciation in melanocytes. Anti-tyrosinase activities of compound 1a (IC 50 = 12.04 μM) and 1b (IC 50 = 8.99 μM) were about 5 times higher than that of kojic acid (IC 50 = 50.20 μM). These results indicate that compound 1a and 1b decreased melanin synthesis via deactivation of tyrosisnas in a dose-dependent manner (Fig. 1) .
To determine inhibition type of hydroxamic acid derivatives on mushroom tyrosinase, the kinetic behavior was studied. A kinetic study of L-tyrosine oxidation catalyzed by mushroom tyrosinase was accomplished in the presence of compound 1a, 1b and kojic acid (Fig. 2) . Michaelis-Menten constant (K m value) of compound 1a and 1b were different from that of kojic acid. Through Lineweaver-Burk plot data, it was found that compound 1a and 1b were non-competitive inhibitor. 13 These behavior indicated that hydroxamic acid moiety did not block the active site itself but bound to an other essential domain of tyrosinase.
Conclusion
The inhibitory effects of hydroxamic acid derivatives on the melanogenesis have been studied. Results showed that hydroxamic acid derivatives strongly inhibited melanin synthesis via deactivation of tyrosinase. The presence of hydroxamic acid moiety was critical for anti-melanogenic activity. Although hydroxamic acid has metal ion chelating ability which is similar to that kojic acid, its anti-tyrosinase mechanism was different from that of kojic acid. Further studies on their more detail inhibition pathway in melanogenesis are underway.
Experimental Section
Preparation of Methyl 4-(Adamantanylcarbamoyl)-benzoate (2). 1-Adamantanecarboxylic acid 2 (9.0 g, 0.05 mol) was dissolved in 100 mL of SOCl 2 at 0 o C and refluxed for 1 h. The SOCl 2 was removed in vacuo, and crude acid chloride was dissolved in CH 2 Cl 2 (50 mL). To a solution of methyl 4-aminobenzoate (7.5 g, 0.05 mol) in pyridine (100 mL) was added prepared acid chloride solution. The reaction mixture was stirred for 4 h at room temperature. The reaction mixture was concentrated in vacuo and the residue was extracted with ethyl acetate (250 mL), washed with water. The organic layer was dried with anhydrous MgSO 4 and concentrated to give a crude product. The resultant was purified by crystallization from dichloromethane-hexane to give a methyl 4-(adamantanylcarbamoyl)benzoate 2 (13.3 g) in 85% yields. R f = 0.68 (2:1 EtOAc/hexanes). μL of mushroom tyrosinase (1600 U/mL) was added. The amount of dopachrome produced in the reaction mixture was determined against a blank (solution without enzyme) at 475 nm (OD 475 ) using a spectrophotometer (Shimadzu Corporation, Kyoto, Japan Measurements of Melanin Content and Cell Viability. Melanin content and cell number were measured in melan-a melanocytes. One hundred thousand cells were seeded into each well of 24 well plate and drugs were treated in triplicate. Medium was changed daily and after 4 days of culture, the cells were lysed with 1 mL of 1 N NaOH and pipetted repeatedly to homogenize. For analysis, 200 μL of each crude cell extracts were transferred into 96-well plates. Relative melanin content was measured at 400 nm with an enzyme-linked immunosorbent assay (ELISA) reader (BioTex instruments). Cell viability was determined by the crystal violet assay. The culture medium was removed from the 24-well culture plates and replaced with 0.5 mL of 0.1% crystal violet in 10% ethanol per well. The plates were stained for 5 min at room temperature and rinsed with D.W four times. Crystal violet retained by adherent cell was extracted with mL of 95% ethanol. Absorbance was determined at 540 nm using ELISA reader.
